DC-101
N/A
Report date: 2025/12/31 10:07:38
Base Information
Drug NameDC-101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesImclone Systems Llc
China Registration ClassN/A
Develop Information
Active CompaniesTianjin Medical University Cancer Institute And Hospital
Inactive CompaniesImclone Systems Llc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A